ezetimibe has been researched along with Adverse Drug Event in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Kim, HL; Kim, MA; Kim, SH; Lim, WH; Seo, JB; Zo, JH | 1 |
| Annoni, F; Caputo, S; Cremona, AM; Grandi, AM; Grossi, P; Guasti, L; Marchesi, C; Maresca, AM; Nicolini, E; Rizzi, L | 1 |
| Gartlehner, G; Glechner, A; Kaminski-Hartenthaler, A; Mahlknecht, P; Nußbaumer, B | 1 |
| David, MC; Hollingworth, SA; Martin, JH; Ostino, R; Tett, SE | 1 |
| Deng, SB; Du, JL; Gao, YL; Jing, XD; Liu, YJ; Nie, HJ; Ran, D; She, Q | 1 |
| Abu Rajab, M; Kaplan, MM | 1 |
1 review(s) available for ezetimibe and Adverse Drug Event
| Article | Year |
|---|---|
Ezetimibe-Statin Combination Therapy.
Topics: Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Anticholesteremic Agents; Causality; Comorbidity; Death, Sudden, Cardiac; Diabetes Mellitus; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Evidence-Based Medicine; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Middle Aged; Risk Factors; Survival Rate; Treatment Outcome | 2016 |
2 trial(s) available for ezetimibe and Adverse Drug Event
| Article | Year |
|---|---|
Dyslipidemia in HIV-positive patients: a randomized, controlled, prospective study on ezetimibe+fenofibrate versus pravastatin monotherapy.
Topics: Adult; Anticholesteremic Agents; Azetidines; Drug-Related Side Effects and Adverse Reactions; Dyslipidemias; Ezetimibe; Female; Fenofibrate; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Pravastatin; Prospective Studies; Treatment Outcome | 2014 |
A randomized, controlled comparison of different intensive lipid-lowering therapies in Chinese patients with non-ST-elevation acute coronary syndrome (NSTE-ACS): Ezetimibe and rosuvastatin versus high-dose rosuvastatin.
Topics: Acute Coronary Syndrome; Aged; Anticholesteremic Agents; C-Reactive Protein; China; Cholesterol, LDL; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Ezetimibe; Female; Humans; Male; Middle Aged; Rosuvastatin Calcium | 2017 |
5 other study(ies) available for ezetimibe and Adverse Drug Event
| Article | Year |
|---|---|
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Efficacy, safety and clinical outcome associated with statin use for primary prevention in Korean patients with low-density lipoprotein cholesterol level ≥ 190 mg/dL: A retrospective cohort study.
Topics: Aged; Cholesterol, LDL; Drug-Related Side Effects and Adverse Reactions; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Primary Prevention; Republic of Korea; Retrospective Studies | 2023 |
Ezetimibe: Use, costs, and adverse events in Australia.
Topics: Anticholesteremic Agents; Australia; Drug Costs; Drug Prescriptions; Drug Utilization Review; Drug-Related Side Effects and Adverse Reactions; Ezetimibe; Ezetimibe, Simvastatin Drug Combination; Humans; Hypercholesterolemia; Pharmacoepidemiology; Practice Patterns, Physicians'; Risk Factors; Time Factors; Treatment Outcome | 2017 |
Statins in primary biliary cirrhosis: are they safe?
Topics: Aged; Alanine Transaminase; Anticholesteremic Agents; Azetidines; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Ezetimibe; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Male; Middle Aged; Probability; Retrospective Studies; Risk Assessment; Safety Management; Severity of Illness Index; Treatment Outcome | 2010 |